Chris Platt Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1320 Maricopa Hwy, Ojai, CA 93023 Phone: 805-646-7211 Fax: 805-646-6480 |
Tannen Miller Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 404 N Montgomery St Unit A, Ojai, CA 93023 Phone: 209-247-2398 |
Insoon Jang, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11496 N Ventura Ave, Ojai, CA 93023 Phone: 805-646-6697 Fax: 805-646-0627 |
Fred Leivo Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 202 E Ojai Ave, Ojai, CA 93023 Phone: 805-646-7272 Fax: 805-646-1614 |
Hanh Platt Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1320 Maricopa Hwy, Ojai, CA 93023 Phone: 805-646-7211 Fax: 805-646-6480 |
Dr. Carol Suzanne Millage, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 575 E Villanova Rd, Ojai, CA 93023 Phone: 805-646-3646 |
Ashley W Echols, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11496 N Ventura Ave, Ojai, CA 93023 Phone: 805-646-6697 Fax: 805-646-6027 |
Craig Lynwood Edwards, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11496 N Ventura Ave, Ojai, CA 93023 Phone: 805-646-6697 Fax: 805-646-0627 |
News Archive
The Premier healthcare alliance is urging that, if scheduled 2 percent cuts take effect, they not apply to hospitals that have already reduced costs.
New insights into how human cytomegalovirus, the leading cause of birth defects associated with infection spreads from pregnant mother to fetus and from organ to organ in newborns provides translational researchers an exciting new avenue for investigation that may lead to the development of therapeutic interventions.
IRIN examines how some major international aid donors report their donations in a way that inflates their contributions.
Therapies leading to longer life for HIV patients have paradoxically increased the prevalence of this condition. Identifying biological markers for the development of HIV–associated dementia is critical both for diagnosing the disorder and for understanding its underlying mechanisms.
Researchers at the University of Pennsylvania School of Medicine have determined the precise molecular details of how Erbitux, a recently approved colorectal cancer drug, binds to its target on cancer cells. Knowing this chemical configuration will lead to better drug design for this family of cancer medications.
› Verified 4 days ago